Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Abstract

The consistency of the response in patients with ejection fractions of <25% to <65% distinguishes the effects of empagliflozin from other drugs that have been evaluated across the full spectrum of ejection fractions in patients with heart failure.